title: Slow progression of exudative age related macular degeneration associated with hypertrophy of the retinal pigment epithelium.
abstract: BACKGROUND
  Choroidal neovascular (CNV) lesions in younger patients are often accompanied by the appearance of a surrounding ring of pigment that is associated with disease regression or slowed disease progression. In older patients with age-related macular degeneration (AMD), however, hypertrophy of the retinal pigment epithelium (RPE) is known to occur but has not previously been reported to be associated with CNV regression. This report describes the clinical course of a case series of AMD patients with pigment hypertrophy adjacent to CNV associated with stabilization of the CNV lesion.
  
  
  METHODS
  A retrospective analysis of exudative AMD patients seen by a single retina specialist over a 7-year period.
  
  
  RESULTS
  Retrospective analysis of 955 exudative AMD patients revealed pigment hypertrophy associated with CNV in 33 patients. A ring of pigment surrounded CNV in 6 of these. Three representative patients are presented to illustrate the decrease in macular edema, reduced fluorescein leakage and slowed CNV progression that was associated with a pigment ring around CNV in AMD. Pigment hypertrophy was associated with blocked fluorescein leakage and exudative AMD patients with a complete pigment ring maintained stable visual acuity, macular edema, fluorescein leakage and CNV lesion size without treatment for intervals of up to 21 months.
  
  
  CONCLUSIONS
  We report slowed disease progression in AMD patients who develop pigment around CNV. The slow rate of disease progression in the AMD patient subgroup having a pigment ring is a factor to consider in determining the treatment interval for exudative AMD patients.
authors: Neural Stem Cell Institute and Athghin Biotechnology Inc, Albany, NY, 12206, USA ; Capital Region Retina, PLlc, Albany, NY, 12206, USA.
authors: Jeffrey
authors: J
authors: Stern
authors: Neural Stem Cell Institute and Athghin Biotechnology Inc, Albany, NY, 12206, USA.
authors: David
authors: D
authors: Eveleth
authors: Capital Region Retina, PLlc, Albany, NY, 12206, USA.
authors: Jennifer
authors: J
authors: Masula
authors: Neural Stem Cell Institute and Athghin Biotechnology Inc, Albany, NY, 12206, USA.
authors: Sally
authors: S
authors: Temple
keywords: macular degeneration, AMD, choroidal neovascularization, CNV, retinal pigment epithelium, RPE, AMD treatment interval, RPE wound healing